Universe Pharmaceuticals INC Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Monitoring Framework
Key Performance Indicators
Annual Revenue Annually17.9M
Net Income (Loss) Annually-3.7M
Gross Profit Margin Annually3,528.0%
Watch Items
- Nasdaq Listing Compliance and Delisting RisksTrigger: Minimum bid price below $1.00 or delayed financial filingsAction: Monitor SEC filings and potential reverse stock splits or share consolidations to maintain listing requirements.
- Concentration of Voting Power under Dual-Class Share StructureTrigger: CEO voting power changes from current ~75%Action: Evaluate corporate governance risks and impact of dual-class structure implemented on February 13, 2026.
Research as of 20 Jun 2026